NCT04924075 2026-04-13
MK-6482-015
Merck Sharp & Dohme LLC
Phase 2 Recruiting
Clinical Trials
5 trialsNCT04895748 2026-03-03
DFF332 as a Single Agent and in Combination With Everolimus & Immuno-Oncology Agents in Advanced/Relapsed Renal Cancer & Other Malignancies
Novartis
Phase 1 Terminated
NCT07282587 2026-02-27
Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma
Jazz Pharmaceuticals
Phase 2 Recruiting
NCT04711135 2026-02-12
NETTER-P
Advanced Accelerator Applications
Phase 2 Active not recruiting
NCT04187404 2026-01-30
Spencer
Enterome
Phase 1/2 Terminated